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Intercellular adhesion molecule-1 (ICAM-1), vascular cell 
adhesion molecule-l (VCAM-l), and endothelial leukocyte 
adhesion molecule-l (ELAM-I, E-selectin) are endothelial 
surface molecules that playa role for leukocyte recruitment 
to sites of inflammation, e.g., during contact hypersensitiv-
ity. We studied the effects of sensitizing agents (2,4-dinitro-
benzenesulfonic acid, metal salt hap tens) and chemically 
related substances on endothelial adhesion molecule 
expression. Using flow cytometry and an enzyme-linked im-
munosorbent assay, NiCI2 and, to a lesser extent, CoCI2 were 
found to up-regulate ICAM-I, VCAM-I, and ELAM-I ex-
pression on cultured human umbilical vein endothelium 
whereas the other substances tested showed no effects. In-
duction of adhesion molecules by NiCl2 required de novo 
mRNA and protein synthesis. Up-regulation could be 
blocked by kinase inhibitor H-7 but not staurosporine, sug-
gesting involvement of phosphorylation events independent 
of protein kinase C activation. Concomitant application of 
Ligand interactions between vascular endothelial cells and blood leukocytes play an ~mport~nt role in tl~e regu-lation of cell traffickmg at sites of ImmunologiC chal-lenge (see [1] for review). Surface expression of endothe-lial adhesion molecules such as intercellular adhesion 
molecule-l (ICAM-1), vascular cell adhesion molecule-1 (VCAM-
1), and endothelial leukocyte adhesion molecule-1 (ELAM-1, E-se-
lection) has been demonstrated to be involved in leukocyte recruit-
ment during the pathogenesis of many dermatologic disorders 
[2 - 7]. I CAM-1 mediates adhesion oflymphocytes, polymorphonu-
clear cells, and monocytes by binding to the pz-integrins lympho-
Manuscript received August 19, 1992; accepted for publication January 
28, 1993. 
Reprint requests to: Dr. Matthias Goebeler, Institute of Experimental 
Dermatology, von-Esmarch-Strasse 56, D-4400 Munster, FRG. 
This work was presented in part at the 22nd Annual Meeting of the 
ESDR, London, England, April 4-7, 1992. 
Abbreviations: DNBSOJ , 2,4-dinitrobenzenesulfonic acid; ELAM-1, en-
dothelial leukocyte adhesion molecule; H-7, 1-(5-isoquinolinesulfonyl)-2-
methyl pi perazine dihydrochloride; 0 D, optical density; V CAM-1, vascular 
cell adhesion molecule-I. 
NiCl2 and neutralizing antibodies to IL-1 did not block up-
regulation by the hapten demonstrating that the latter did not 
act via an IL-I-dependent autocrine mechanism. Regarding 
ELAM-1 induction, pre-treatment for 24 h with NiC12 pro-
duced hyporesponsiveness to IL-1 and TNF-a upon restimu-
lation, suggesting that NiCl2 and these cytokines may par-
tially share a common pathway of activation. In addition, 
analysis of cultured foreskin specimens revealed that NiCI2 
may induce up-regulation ofELAM-l on microvascular en-
dothelium in vivo. 
Our data demonstrate that both Ni++ and Co++ to which 
simultaneous contact sensitivity is frequently observed have 
the ability to directly up-regulate endothelial adhesion mole-
cules. This shared property may represent an adjuvant mecha-
nism that promotes sensitization and elicitation events in 
contact hypersensitivity to these haptens. ] Invest Dermatol 
100:759-765,1993 
cyte function-associated antigen 1 (LFA-1) or Mac-1 [8-13]. 
VCAM-1, like ICAM-1 a member of the immunoglobulin (Ig) 
superfamily, is involved in the recruitment of lymphocytes and 
monocytes via its ligand VLA-4, a p,-integrin [13-16]. ELAM-1 
binds polymorphonuclear cells and monocytes as well as a subset of 
memory T cells via sialylated, fucosylated polylactosamines [17-
23]. The expression pattern of adhesion molecules on endothelium 
is modulated by cytokines such as tumor-necrosis factor a (TNF-a) 
and interleukin 1 (IL-1) [14,24-26]. In allergic contact derm~titis, 
allergens may induce the release of cytokines by antigen-specific T 
cells and epidermal cells [27]. These cytokines are supposed to s~b­
sequently up-regulate ICAM-l, VCAM-l, and ELAM-1 expreSSIOn 
on dermal microvascular endothelium [28]. However, it is not. yet 
clear whether allergens might also directly activate endothelium 
during the initiation of contact allergy. 
We therefore analyzed the effect of various haptens and 
chemically related agents on adhesion molecule expresslO~ by cul-
tured endothelial cells. Out of the substances tested, NIClz and 
CoClz were found to directly increase the expression of ICAM-1, 
VCAM-1, and ELAM-1. We demonstrate that phosphorylat!on 
events are involved in NiCl2-induced up-regulation of adheSIOn 
molecules. An autocrine mechanism via IL-l was not found to be 
0022-202X/93/S06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 
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responsible for up-regulation. Analysis of foreskin explants revealed 
that NiClz may also increase expression of adhesion molecules, 
especially ELAM-l, by microvascular endothelial cells in intact 
skin. 
MATERIALS AND METHODS 
Cell Culture Human umbilical vein endothelial cells (HUVEe) 
were isolated by the method of Gimbrone [29] and cultured in 
medium M199 supplemented with 20% fetal calf serum, 10% 
human serum, 100 u/ml penicillin, 100 Ilg/ml streptomycin, 
2 mM L-glutamin, and 1 mM sodium pyruvate (all obtained 
from Biochrom, Berlin, FRG). Cells were characterized as endothe-
lial by their cobblestone morphology and the presence of fac-
tor VIII - related antigen. HUVEC were used between passages 4 
and 12. 
Materials Recombinant human IL-1p and TNF-a were pur-
chased from Boehringer Mannheim (Mannheim, FRG). NiClz, 
NiS04, MnClz, CuClz, and KZCr04 were obtained from Merck (Darmstadt, FRG); CrCI3 , ZnClz, CoClz from Sigma (Deisenho-
fen, FRG); K2Cr207 from Fluka (Buchs, Switzerland); AICI3 from 
Aldrich-Chemie (Steinheim, FRG); and 2,4-dinitrobenzenesul-
fonic acid (DNBS03 ) from' Eastman Kodak (Rochester, NY). All 
chemicals were of analytical grade and were dissolved in endotoxin-
free water at 200 mM or, concerning K2Cr04 and K2Cr20 7, at 
0.5 mM. Stock solutions were found to be endotoxin free when 
tested in the Limulus amebocyte lysate assay (Sigma; sensitivity, 0.05 
endotoxin U /ml). For stimulation experiments, substances were 
used at a concentration of2 mM; however, due to cytotoxic effects, 
CuCl2 was diluted to a final concentration of 0.2 mM and both 
K2Cr04 and KZCrZ0 7 to 5 IlM. Actinomycin 0 and cycloheximide 
were purchased from Sigma. Kinase inhibitors 1-{5-isoquinolinesu-
fonyl)-2-methylpiperazine dihydrochloride (H-7) and staurospor-
ine were obtained from Calbiochem (Bad Soden, FRG) and were 
dissolved in water or ~imethyl sulfoxide, respectively. Affinity-pur-
ified polyclonal r~bblt antiserum to human IL-l was purchased 
from Endogen (via BlOmar, Marburg, FRG), rabbit antiserum to 
factor VIII-related antigen from Behringwerke {Marburg, FRG}. 
VCAM-1 was detected br a m~:moclonal mouse IgG l antibody (MoAb) obtamed from Bntlsh Biotechnology (via Biermann, Bad 
Nauheim, ~RG) or by mouse MoAb 1.4C3 [30] that had been 
kll1dly provided by D. o . Haskard [Department of Medicine (Rheu-
matology), Hammersmith Hospital, London, UK]. For detection of 
ELAM-1 a mouse MoAb purchased from British Biotechnology was 
empl~yed. ICA~-1 as well as fluorescein isothiocyanate- or 
peroxidase-conJugated second-stage goat-anti-mouse or goat-
anti-rabbit F(ab)' 2 antibodies were obtained from Immunotech (via 
Dianova, Hamburg, FRG). For detection of HLA-DR, MoAb 
91007 (mouse IgG 1) was used [31] . 
Detection ofICAM-1, VCAM-1, and ELAM-1 Expression by 
Fluorescence-Activated Cell Sorter (FACS) Analysis After 
incubation with mediators in T25 culture flasks (Falcon), HUVEC 
were trypsinized [0.05% trypsin, 0.02% EDT A (Biochrom); maxi-
mum 4 min], was~ed, suspended in 50% ~ormal goat serum/phos-
phate-buffered sal me to prevent non-specific binding, and then in-
cubated with appropriate dilutions of primary antibody for 60 min 
at 4°C. Cells were again washed and then incubated with fluores-
cein isothiocyanate-cOl~ugated secondary antibody. Subsequently, 
propidium iodide was added to allow determination of cell viability 
and exclusion of non-viable cells. HUVEC were immediately ana-
lyzed on a FACScan using Lysis Software (Becton Dickinson, Hei-
delberg, FRG). Net fluorescence was calculated as the mean fluores-
cence channel of cells stained with MoAb divided by the mean 
fluorescence channel of cells stained with isotype-matched control 
MoAb. 
Enzyme-Linked Intmunosorbant Assays (ELISA) for ICAM-
1, VCAM-1, and ELAM-1 Expression HUVEC (5 X 103/ 
well) were seeded into 96-well flat-bottomed micro titer plates (Fal-
con, Becton Dickinson, Heidelberg, FRG) in 100 III medium. After 
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reaching confluence, cells were treated with various concentrations 
of allergens, cytokines, neutralizing antibodies, or metabolic inhibi-
tors for the indicated time as noted in the text. After incubation, 
cells were washed with phosphate-buffered saline, fixed by 0.1 % 
glutaraldehyde for 5 min, and washed again. After inhibiting endog-
enous peroxidase with 0.25% sodium azide in 0.3% H20 2, cells 
were incubated with 1 % bovine serum albumin and 10% fetal calf 
serum for 1 h . Then saturating concentrations of primary antibodies 
against lCAM-1, VCAM-1, and ELAM-1 or isotype control IgG of 
irrelevant specificity were added, which were subsequently detected 
by peroxidase-conjugated secondary antibodies using 1 mM 2,2'-
azino-bis-{3-ethylbenzthiazoline-6-sulfonic acid) and 0.3% HzOz 
in citric acid buffer (pH 4.0) as substrate. After development of the 
color, reaction plates were read at 414 nm on a Titertek Multiscan 
ELISA reader (Flow laboratories, VA) . Net optical densities (aD) 
are given as differences of 00 {mean ± SEM of quadruplicate 
wells} of wells containing specific MoAb and wells incubated with 
isotype control MoAb. 
Tissue Culture Seven normal foreskins obtained from children 
up to 8 years of age in elective surgical circumcision procedures 
were immediately washed three times in RPMl 1640 medium 
(Biochrom, Berlin, FRG) supplemented with 1000 U/ml penicil-
lin, 1 mg/ml streptomycin, and 1 Ilg/ml amphotericin B, cut into 
5 mm X 5 mm pieces and placed into 24-well tissue culture plates 
(Limbro, Flow Laboratories, McLean, V A) as previously described 
[32] . Briefly, to 200 III medium (RPMI 1640 supplemented with 
10% fetal calf serum, 100 U / ml penicillin, 100 Ilg/ ml streptomy-
cin, and 2 mM L-glutamin), 100 III medium containing the media-
tors were added, leading to final concentrations of 20 U /ml IL-1P 
or 0.7 mM NiCI2. In control groups NiCl2 was replaced by endo-
toxin-free water. In all experiments 50 Ilg/ml polymyxin B sulfate 
(Sigma) has been added to the medium to avoid lipopolysac-
charide-induced upregulation of adhesion molecules. After 6 h of 
incubation foreskin specimens were harvested and processed for 
immuno histochemistry. 
Immunohistochemistry Cryostat specimens of foreskin were 
cut, fixed in acetone for 10 min, and stained according to the im-
munoperoxidase method using 3-amino-9-ethylcarbazole as cllfo-
mogen [33]. Serial sections were labeled for ICAM-l, VCAM-l , 
and ELAM-l as well as for factor VIII-related antigen to identify 
capillary endothelium. The intensity of endothelial staining for 
adhesion molecules was semiquantitatively graded according to cri-
teria similar to those ofMessadi et al [32]: 0, no detectable staining of 
endothelial cells; 1, weak focal staining of venules; 2, weak to mod-
erate staining of most venules; 3, intense staining of most venules; 4, 
intense staining of whole venules. Grading was performed by two 
observers in a "blind" fashion. 
RESULTS 
Effect of Haptens and Related Chemical Compounds on 
Surface Expression of ICAM-1, VCAM-1, and ELAM-l 
Unstimulated HUVEC revealed a moderate ICAM-l surface ex-
pression, VCAM-l was almost undetectable, and ELAM-1 could 
not be demonstrated at all as determined by FACS analysis. Upon 
stimulation with NiCl2 (or NiS04, data not shown) for 6 h a strong 
up-regulation of all three adhesion molecules was observed (Figs 1 
and 2). Regarding CoCl2 similar results were obtained; however, 
the degree of up-regulation was less pronounced. Chemically re-
lated metal salts such as MnCI2, CuCI2, and ZnCl2 did not reveal 
any effects on adhesion molecule induction at non-toxic concentra-
tions. The haptens CrCl3 and K2Cr20 7 as well as the potent organic 
hapten DNBS03 did not induce up-regulation either. 
Due to the similarity ofNiCl2 and CoCl2 effects only the first was 
employed for further experiments. The response to NiCl2 was 
found to be dose dependent in a range of 0.5 and 2.0 mM (Fig 3). At 
these concentrations cell viability of NiClz-treated HUVEC was at 
least 90% of that observed for untreated control cells. At concentra-
tions of 5 mM NiCl2 cytotoxic effects were detected (data not 
shown). In time-course experiments peak expression of VCAM-l 
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figure 1. Surface expression of ICAM-l, VCAM-l, and ELAM-t on 
HUVEC 5 h after treatment with 1) culture medium alone, 2) 2 111M AlCl" 
3) 2 ruM erCl" 4) 5 JIM K2CrO., 5) 5 11M K2CrP7' 6) 2 111M MnCI2 , 7) 
ZmM CoCI2 , 8) 2 mM NiCI2 , 9) 0.2 mM CuCI2 , 10) 2 111M ZnCI2 , and 
II) 2 m.M DNBSO,. Cells were measured by FACS analysis. Data are 
Ihown as mcan ± SEM of net fluorescences of five independent experi-
ments. Asterisks, statistically significant differences as comparcd to untreated 
control groups (p :5 0.01, Student t test). 
and ELAM-1 was observed at 5 h after addition of 2 mM NiCI2 , 
whereas I CAM-1 was found to be expressed at high levels from 5 h 
up to 48 h . There was no influence of NiCI2 on endothelial HLA-
DR expression (Fig 3). 
Effect otMetabolic Inhibitors, Neutralizing Antibodies, and 
PharD1acologic Agents on NiCl2-Induced Adhesion Mole-
cule Expression To investigate whether ICAM-1, VCAM-1, 
3Ild ELAM-1 up-regulation is dependent on mRNA or protein syn-
thesis, actinomycin D or cycloheximide were added concomitantly 
with 2 tn.M NiCI2 to HUVEC. Cells were cultured in microtiter 
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Figure 2. Surface expression of ICAM-I, VCAM-l, and ELAM-l on 
HUVEC without or 5 h after treatment with 2 mM NiCI2 • FACS profiles of 
cells stained with control IgG and MoAb against adhesion molecules are 
depicted; the latter are shown shaded. 
plates for 5 h and expression of ad hesion molecules was subse-
quently measured by ELISA as described in Materials and Methods. 
Both actinomycin D and cycloheximide were found to almost com-
pletely inhibit induction of ICAM-1 , VCAM-1, and ELAM-1 
(Table I). 
To a.ssess v.:hether NiCl2-induced up-regulation of adhesion mol-
ecules IS medIated through an autocrine mechanism involving IL-1 , 
the latter was blocke~ by addition of neutralizing antibodies. Com-
pared to control antisera IL-1Q' - and -p-neutralizing antibodies 
showed no effect on NiCl2 induction of ICAM-1, VCAM-1, and 
ELAM-1 , whereas IL-1P -induced up-regulation of these molecules 
was inhibited (Table II). 
T~ determine the r.ole of protein kinase function on signal trans-
d~c.tlon followmg NICl2 treatment the effect of protein kinase in-
hibitors I:i-7 and. staurosporine on adhesion molecule expression 
w~s studle~. USll1g 100 11M staurosporine neither IL-1P- nor 
NICl2-medlated up-regulation was inhibited, whereas 50 J-lM H-7 
lead to a marked decrease of ICAM-1 and VCAM-1 up-regulation 
and a less pronounced inhibition of ELAM-1 induction (Table I). 
Tachyphylaxis ofELAM-l Induction to NiCl2 and Cytokines 
HUVEC pre-treated with NiCI2 , IL-1P, and TNF-Q' for 24 h were 
restimulated with these mediators in each possible combination for 
5 h and analyzed for ELAM-1 expression by ELISA (Table III). To 
ex.clude that potential cytotoxicity after 24 h of NiCl2 treatment 
Imght be the reason for low OD values, experiments were repro-
duced by FACS analysis, which could be restricted to viable cells 
(data not shown). As already reported [26,34J both cytokines pro-
duce tachyphylaxis after pre-treatment and restimulation by the 
same cytokine but no cross-tachyphylaxis to each other. Pre-treat-
ment with NiCl2 inhibited up-regulation ofELAM-l after restimu-
lation by both IL-1P and TNF-Q'. In contrast, restimulation by 
NiCl2 of HUVEC pre-treated by ei ther IL-1P or TNF-Q' reveaJed 
no cross-tachyphylaxis. 
Effect of NiCl2 on Capillary Endothelium of Skin Ex-
plants Foreskin specimens ~ultured in 24-well plates were ex-
posed to either 0.7 mM NiCl2 or 20 U Iml IL-tp for 6 h. Compared 
to control groups treated solely with endotoxin-free water both 
mediators lead to a significant increase of the staining intensity for 
ELAM-1 as determined by immunohistochemistry (Fig 4, Table 
IV) . Compared to the relatively strong ICAM-1 staining of control 
skin only a slight, non-significant increase of microvascular ICAM-
1 expression was observed in NiCI2 - and IL-1p-treated foreskin 
explants. The extent and intensity ofVCAM-1 staining was consid-
erably less pronounced in stimulated and control skin specimens and 
did not reveal significant differences either (data not shown) . 
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Figure 3. Response characteristics of HUVEC treated with NiCI2 regard-
ing expression of adhesion molecules as determined by FACS analysis: A) 
concentration dependence (assayed at 5 h); B) time dependence (at 2 mM 
NiCI2) . Results are given as mean ± SEM of net f1uorescences of three 
experiments. In B, influence of NiCl2 on HLA-DR surface expression is 
additionally shown. 
DISCUSSION 
In the present study we analyzed the e!fects of various haptens and 
chemically related agents on endothelIal cells. In contrast to other 
divalent kations such as MnCl2 , CuCl2 , and ZnCl2 , Ni++ and Co++ 
lead to up-regulation of endothelial ICAM-l, VCAM-l, and 
ELAM-l expression. Other common sensitizing agents as K2Cr207 
and CrCl3 or the potent organic hapten DNBS03 did not show 
activation effects either. Regarding ICAM-l, these observations are 
in accordance with preliminary results communicated by Wildner et 
al. * except a slight up-regulation of ICAM-l by DNBS03 , which 
w e could not confirm with even up to tenfold higher concentrations 
in our study. The effect shared by Ni++ and Co++ m ay have clinical 
implications: individuals with Ni++ allergy are frequently also sen-
sitive to Co++ [35 -37]. The high prevalence of co-sensitivity to 
Ni++ and Co++ has been speculated to be due to individual suscepti-
• Wildner 0, Lipkow T, Knop J: Increased expression of intercel lular 
adhesion molecule- l on human umbilical vein endothelial cells after treat-
ment with contact allergen (abstr). ] Invest Dermatol 96:1028, 1991 
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Table I. Effect of Metabolic and Pharmacologic Inhibitors on 
Endothelial Adhesion Molecule Induction by NiCI2" 
Percent Inhibition 
Treatment (5 h) Experiment ICAM-l VCAM-l ELAM-l 
Actinomycin D (0.2Ilg/ml) 
NiCl2 (2 mM) 1 89 100 93 
2 100 100 100 
3 100 96 100 
Cycloheximide (10 Ilg/ml) 
NiCl2 (2 mM) 1 100 100 51 
2 100 100 100 
3 100 100 100 
H-7 (50 11M) 
NiC12 (2 mM) 1 100 100 73 
2 100 100 31 
3 57 81 74 
IL-lP (5 U/ ml) 1 81 97 51 
2 60 76 28 
3 55 98 52 
Staurosporine (100 nM) 
NiCI2 (2mM) 1 (-83) (-35) (- 24) 
2 (-19) (-1 6) (-20) 
3 (-22) (-27) (-20) 
IL-lP (5 U/ ml) 1 (- 14) (-4) a 
2 (-61) (-87) (-63) 
3 (-3) 5 9 
• The effect of metabolic and pharmacologic inhibitors upon NiCl,-induced up-regu-
lation ofICAM-I, VCAM-l , and ELAM-l by HUVEC as determined by ELISA. Data 
of three independent experiments are shown. Agents were added coincidentially wirb 
NiCl2 or IL-lpand left in the medium for a S-h period. Net 00 were determined from 
quadruplicate wells at one time point as described ill Materials alld Methods. The SEM for 
each net 00 was below 8% in all cases. Percent inhibition is calculated as 1-
[(mediator-induced expression in the presence of inhibitor - basal expression in the 
presence ofinhibitor)/ (mediator-induced expression in the absence of inhibitor - basal 
expression in the absence of inhibitor)]. Negative percentages (in brackets) reflect 
up-regulation. 
bility, concomitant occurrence of both m etals in alloys, similarity in 
atomic number and molecular weight, and as yet unidentified im-
munologic interactions [35 - 38]. Sensitization experiments and 
analysis ofT-cell clones specific for Ni++ or Co++, however, demon-
strated that these metals do not behave as cross-sensitizing haptens 
[38-41]. Co-sensitivity has rather been assumed to be due to a 
non-specific mechanism [36,38]. Induction of endothelial adhesion 
Table II. Effect of N eutralizing Antibodies to IL-1a 
and P upon NiCl2-Induced Up-Regulation of Endothelial 
Adhesion Molecules" 
OD4I • 
Treatment (5 h) ICAM-l VCAM-l ELAM-1 
Experiment 1 
Control rabbit IgG 0.86 ± 0.02 0.36 ± 0.02 0.32 ± 0.01 
Anti - IL-laIP (1:20) 1.00 ± 0.03 0.53 ± 0.01 0.70 ± 0.01 
NiCl2 (2 mM) 1.27 ± 0.06 0.90 ± 0.03 1.21 ± 0.04 
NiCl2 + anti - IL-1aIP 1.19 ± 0.03 0.92 ± 0.01 1.24 ± 0.05 
IL-1P (5 Wml) 1.32 ± 0.D3 1.09 ± 0.04 1.47 ± 0.05 
IL-lP + anti-IL-laIP 1.06 ± 0.07 0.51 ± 0.02 0.71 ± 0.02 
Experiment 2 
Control rabbit IgG 1.25 ± 0.05 0.28 ± 0.05 0.29 ± 0.02 
Anti-IL-1a/p (1 :20) 1.48 ± 0.06 0.51 ± 0.02 1.00 ± 0.04 
NiC12 (2 mM) 1.60 ± 0.06 0.86 ± 0.04 1.69 ± 0.05 
NiCl2 + anti-IL-la/P 1.63 ± 0.06 0.90 ± 0.05 1.67 ± 0.05 
IL-1P (5 U/ ml) 1.74 ± 0.06 1.37 ± 0.03 1.82 ± 0.06 
IL-IP + anti - IL-1aIP 1.44 ± 0.03 0.30 ± 0.05 0.90 ±0.O8 
• Cells were treated coincidemially for 5 h with NiCl2 orIL-lP and anti - IL-Ia/ p or 
control rabbit IgG, respectively. Induction of adhesion molecules was determined by 
ELISA. Values are means ± SEM of quadruplicate wells. Data from two independent 
experiments arc shown. 
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Table III. NiCl2-Induced ELAM-l Induction 
and Tachyphylaxis· 
Percent Inhibition of 
Restimulation (5 h) 
Pretreatment NiCl2 TNF-a IL-1P 
(24 h) Experiment (2mM) (0.5 ng/ml) (5 Ujml) 
NiCl2 (2 m.M) 1 99 84 85 
2 92 88 82 
3 89 91 88 
TNF-a (0.5 ng/ml) 1 22 77 6 
2 (-12) 29 0 
3 22 78 9 
1L-1P (5 U Iml) 1 12 8 63 
2 9 2 37 
3 29 22 71 
• Tachy phylaxis to NiCI2 and cytokincs regarding ELAM·1 induction upon restimu-
baon as determined by ELISA. Data of three independent experiments arc shown, 
which were confirmed in an additional experiment by f1ow-cytometric analysis. Per-
etntinhibition is calcul.ted from nctODofquadruplicate wells (SEM S 8%} as defined 
in Table 1. 
molecules, which appears as a shared property of Ni++ and Co++, 
may thus refer to such processes. To analyze its mode of action, 
up-regulation of ICAM-l, VCAM-l, and ELAM-l by Ni++ was 
compared to that of other stimuli, i.e., cytokines. Ni++-induced 
up-regulation of VCAM-l and ELAM-l on endothelium lead to 
maximal expression levels at 5 h and decreased thereafter, whereas 
lCAM-l expression reached its maximum at 24 h after stimulation. 
Ni++ had no effect on HLA-DR expression, suggesting a rather 
lpecific mode of action. As demonstrated by inhibition with actino-
mycin D and cycloheximide up-regulation by Ni++ depends on de 
novo synthesis of mRNA and protein. Time kinetics, dependency on 
mRN A and rrotein synthesis, and specificity of Ni++ -mediated up-
regulation 0 adhesion molecules are similar to those properties that 
have previously been reported for cytokines as TNF-a and IL-l 
[24 - 26,34]' We therefore speculated whether the effects of Ni++ 
might be rnediated by cytokine induction and subsequent autocrine 
stimulation. IL- l is the only known cytokine produced by endothe-
lium that is capable to induce all three adhesion molecules (ICAM-
1, VCAM-l, and ELAM-l). Concomitant application ofNiCl2 and 
neutralizing antibodies to IL-la and P did not lead to inhibition of 
up-regulation, indicating that the latter does not act via an IL- l-
dependent autocrine mechanism. However, we cannot rule out the 
existence of another so far unidentified stimulus that may act in an 
lutocrine fashion. 
We then investigated whether phosphorylation events that have 
been discussed to be involved in cytokine-induced up-regulation of 
Jdhesion rnolecules [34,42-45] are responsible for Ni++-mediated 
effects. The protein kinase C inhibitor staurosporine, which blocks 
PMA-induced expression ofICAM-l [42,43,45] and ELAM-l [43] , 
did not inhibit Ni++-induced up-regulation of adhesion molecules. 
A comparable observation has been made for IL-l and TNF-a, 
whjch could not be inhibited by staurosporine to up-regulate 
lCAM-l and ELAM-l [43,45]. H-7, which is generally supposed to 
be an inhibitor of protein kinase C, did block Ni++ effects. Because 
H-7 additionally inhibits a variety of other protein kinases [46] it 
may be assumed that phosphorylation reactions apart from protein 
kinase C action participate in Ni++-induced up-regulation of adhe-
lion molecules. Long-term (24 h) treatment by H-7 has been shown 
10 suppress protein synthesis in HUVEC [43]. However, in a recent 
Itudy it has been demonstrated that treatment with 50 pM H-7 for 
up to 6 h did not inhibit overall protein synthesis [45]. Regarding 
phosphorylation reactions Ni++ thus revealed a similar mechanism 
of endothelial ICAM-l and ELAM-l induction as IL-l and TNF-a 
143-45] . In addition, our data demonstrate that VCAM-l is regu-
kted in a similar manner as ICAM-l and ELAM-l by Ni++, IL-l, 
lnd TNF-a. 
We then employed tachyphylaxis experiments to investigate the 
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A 
Figure 4. Venules of the superficial dermis of foreskin explants stained for 
ELAM-1 (A) after 6 h in culture alone and (B) after 6 h of culture with 
0.7 mM NiCl2 (bar, 501£111). 
site of Ni++ action. Early observations by Pober et al [26,34J in.di-
cated that restimulation of pre-treated cells by the same cytokll1e 
(either IL-l or TNF-a) caused refractoriness regarding ELAM-l 
induction. Cross-refractoriness, however, was not seen, thus sug-
gesting a model of activation in which refractoriness is due to events 
in proximity to cytokine receptors. When Ni++ - pre-treated 
HUVEC were restimulated by IL-l or TNF-a, ELAM-l mductlOn 
was found to be suppressed. Pre-treatment with IL-l or TNF~a, 
however, did not inhibit induction ofELAM-l by subsequent NI++ 
stimulation. These observations support the conclusion that Ni++ 
acts at a site of the activation pathway rather distal from the receptor 
level that is common to either cytokine. Because it has recently been 
shown that both TNF-a - and IL-l-induced ELAM-l gene tran-
scription in HUVEC are associated with activation of NF-kB [44] 
the question might be raised whether the NF-kB pathway may 
also be a potential mediator of Ni++ -induced effects on endothe-
lium. 
764 GOEBELER ET AL 
Table IV. Effect of NiClz and IL-lP upon Up-Regulation of 
Microvascular ELAM-1 Expression in Organ Culture" 
Treatment (6 h) 
None 
NiCl2 (0.7 mM) 
IL-1P (20 U Iml) 
Intensity of Staining 
ELAM-1 
2.06 ± 0.31 
3.25 ± 0.27b 
2.82 ± 0.26' 
• Relative staining of cryostat sections of foreskin explants for ELAM-1 Was quanti-
fied as described in Materials and Methods. Results are expressed as the mean ± SEM of 
data from seven foreskin explants, which were each assessed twice in a random order by 
two "blind" observers. Statistical significant differences to untreated controls are indi-
cated (I p S 0.01 and ' p S 0.05; Wilcoxon test). 
Ni++ -mediated responses of cultured endothelial cells may differ 
from Ni++ effects in situ. We therefore analyzed foreskin explants 
for expression of adhesion molecules. ELAM-l, which has been 
described to be moderately up-regulated during culture of foreskin 
specimens [32], showed a significant increase of expression after 
stimulation by 0.7 mM Nit+, which was comparable to effects of20 
U jml IL-1p. ICAM-l expression by microvascular endothelium of 
foreskin was found to be slightly elevated after Ni++ application; 
however, due to the relatively strong baseline expression of ICAM-
1, the increase of staining intensity was not as obvious as seen for 
ELAM-l. Interestingly, VCAM-l expression on foreskin endothe-
lium was almost not detectable and did not significantly increase 
after stimulation by either IL-1P or NiClz. This is consistent with 
observations by Norris et al [5] who found that ICAM-l and ELAM-
1, but not VCAM-1, are up-regulated in the skin after UV irradia-
tion. They speculated that additional mechanisms of activation 
might be necessary for VCAM-l-induction in vivo. Recently, Swer-
lick et at [47] demonstrated that IL-l induced up-regulation of 
VCAM-l on HUVEC but not on human dermal microvascular 
endotheli~l cells, which is in accordance with our present observa-
tions. It might thus be concluded that differences in the regulation 
of adhesion molecules may be due to heterogeneity of endothelial 
cells derived from distinct vascular beds. In future studies the effect 
of haptens on cultured dermal microvascular endothelial cells will 
have to be considered. 
Our data regarding Ni++-induced up-regulation of endothelial 
adhesion molecules may be of importance regarding contact aller-
gies. Two recent studies by Picker et at [19] and Shimizu et al [20] 
demonstrated that ELAM-l expression by endothelium mediated, 
besides the previously described recruitment of neutrophils and 
monocytes, the accumulation of memory T cells in the skin. These 
antigen-reactive cells, which lead to an enhanced immune response 
upon re-encountering antigen, playa central role in the patho-
genesis of contact hyper~ensitivity. Thus, it might be supposed 
that Ni++ - andj or Co++ -mduced up-regulation of endothelial ad-
hesion molecules, e.g., ELAM-l, may have a non-specific, adjuvant 
function that amplifies the inflammatory reaction to these hap-
tens. 
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